I like to work in AUD terms and convert analyst forecasts based on the current exchange rate. Nothing saying I am correct though.
I think at the end of the day it is like comparing EBITDA to NPAT, where EBITDA might be interesting to see but NPAT is more relevant to the actual returns you will get IMO.
- Forums
- ASX - By Stock
- RMD
- Fundamental Analysis - Data Choice
Fundamental Analysis - Data Choice, page-2
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$37.60 |
Change
-0.550(1.44%) |
Mkt cap ! $22.96B |
Open | High | Low | Value | Volume |
$37.62 | $37.82 | $37.39 | $22.90M | 609.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7733 | $37.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$37.62 | 611 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7733 | 37.500 |
1 | 9000 | 37.490 |
1 | 7733 | 37.460 |
1 | 415 | 37.410 |
3 | 251 | 37.400 |
Price($) | Vol. | No. |
---|---|---|
37.620 | 611 | 2 |
37.650 | 4402 | 1 |
37.670 | 4456 | 2 |
37.680 | 5205 | 3 |
37.690 | 4402 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online